Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/3569
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.contributor.authorSistema Único de Saúde (Brasil)-
dc.contributor.authorBrasil. Ministério da Saúde-
dc.date.accessioned2021-08-03T15:43:13Z-
dc.date.available2021-08-03T15:43:13Z-
dc.date.issued2020-09-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/3569-
dc.description1 p.-
dc.language.isootherpt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno IV, n. 41.-
dc.subjectTumor de Wilmspt_BR
dc.subjectAntineoplásicos/administração & dosagempt_BR
dc.subjectWilms Tumorpt_BR
dc.subjectAntineoplastic Agents/administration & dosagept_BR
dc.subjectAntineoplásicos/administración & dosificación-
dc.titleTumor de wilms e autorização de procedimento de alta complexidade (APAC)pt_BR
dc.TypeRevistas/Boletinspt_BR
Appears in Collections:Informe SUS - ONCO 2020

Files in This Item:
File Description SizeFormat 
Setembro_2020.pdf440.25 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.